EHE Patient Feature: Tina's Story

After self-advocating for nearly seven years, Tina was finally diagnosed with epithelioid hemangioendothelioma (EHE) in 2024. Even with the emotional and financial burden of years of misdiagnosis, she remains a beacon of positivity. Diagnosed with the rare YAP-TFE3 gene fusion and facing growing tumors, Tina was offered transarterial chemoembolization (TACE). Usually used to treat liver cancer, this minimally invasive procedure has proven successful for Tina so far!